-
公开(公告)号：US10137146B2
公开(公告)日：2018-11-27
申请号：US15983602
申请日：2018-05-18
摘要： A composition of chlorine-free poly-oxygenated metal hydroxide that comprises a clathrate containing oxygen gas molecules, and which may comprise a nutraceutical. In one embodiment, the poly-oxygenated metal hydroxide composition is soluble, and may have particles having a diameter of 212 μm or less. The poly-oxygenated metal hydroxide may comprise of a poly-oxygenated aluminum hydroxide. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form, where the poly-oxygenated aluminum hydroxide is soluble in the fluid.
-
公开(公告)号：US20180271899A1
公开(公告)日：2018-09-27
申请号：US15983602
申请日：2018-05-18
CPC分类号： A61K33/08 , A61K9/0019 , A61K9/0026 , A61K9/1682 , A61K9/5115 , A61K47/6949 , B82Y5/00 , C01F7/02 , C01F7/023 , C01P2004/61 , C01P2004/62 , Y10S977/773
摘要： A composition of chlorine-free poly-oxygenated metal hydroxide that comprises a clathrate containing oxygen gas molecules, and which may comprise a nutraceutical. In one embodiment, the poly-oxygenated metal hydroxide composition is soluble, and may have particles having a diameter of 212 μm or less. The poly-oxygenated metal hydroxide may comprise of a poly-oxygenated aluminum hydroxide. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form, where the poly-oxygenated aluminum hydroxide is soluble in the fluid.
-
公开(公告)号：US10137148B2
公开(公告)日：2018-11-27
申请号：US15984035
申请日：2018-05-18
摘要： A method of treating a mammal, comprising administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of hypoxic carcinoma cells, wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O2) molecules. The carcinoma cells may comprise colon adenocarcinoma cells (CaCo-2). The poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal. The poly-oxygenated metal hydroxide composition can be administered intravenously, directly to carcinoma cells, and orally. The composition may comprise a fluid, where the poly-oxygenated metal hydroxide composition is soluble in the fluid.
-
4.发明申请公开(公告)号：US20180264035A1
公开(公告)日：2018-09-20
申请号：US15984035
申请日：2018-05-18
CPC分类号： A61K33/08 , A61K9/0026 , A61K9/08 , A61K33/06 , A61K47/02 , A61K47/52 , A61K47/6921 , A61K47/6923
摘要： A method of treating a mammal, comprising administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of hypoxic carcinoma cells, wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O2) molecules. The carcinoma cells may comprise colon adenocarcinoma cells (CaCo-2). The poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal. The poly-oxygenated metal hydroxide composition can be administered intravenously, directly to carcinoma cells, and orally. The composition may comprise a fluid, where the poly-oxygenated metal hydroxide composition is soluble in the fluid.
-
5.发明申请公开(公告)号：US20180264034A1
公开(公告)日：2018-09-20
申请号：US15983922
申请日：2018-05-18
CPC分类号： A61K33/08 , A61K9/0026 , A61K9/08 , A61K33/06 , A61K47/02 , A61K47/52 , A61K47/6921 , A61K47/6923 , A61K47/6949
摘要： A method of treating a mammal, comprising administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of hypoxic carcinoma cells, wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O2) molecules. The carcinoma cells may comprise prostrate carcinoma (22Rv1). The poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal. The poly-oxygenated metal hydroxide composition can be administered intravenously, directly to carcinoma cells, and orally. The composition may comprise a fluid, where the poly-oxygenated metal hydroxide composition is soluble in the fluid.
-
公开(公告)号：US20200061232A1
公开(公告)日：2020-02-27
申请号：US16673126
申请日：2019-11-04
IPC分类号： A61L15/42 , A61F13/84 , A61F13/00 , A61L15/46 , A61F13/02 , A61L15/44 , A61M1/00 , A61F13/15
摘要： An oxygen impregnated material suitable for an oxygenating therapeutic to treat wounds with oxygen. The impregnated material avoids the applicational complications associated with conventional oxygen therapeutics, such as reliance on gaseous oxygen, systemic toxicity, and patient immobility. This impregnated material can be used, for example, in bandage-type dressings, or a drape of a vacuum-assisted closure (VAC). This impregnated material can also be used in a diaper to treat and reduce the formation of a rash on the skin.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.015 秒)
